Lanying Du, PhD

Du, Lanying-cropped.jpg

Co-Head, Laboratory of Viral Immunology
Associate Member, Lindsley F. Kimball Research Institute

Research Area

The research focus of the Laboratory of Viral Immunology is on the development of antiviral therapeutic agents and vaccines for the treatment and prevention of HIV infection/AIDS and other emerging and remerging infectious diseases caused by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza viruses, as well as the blood transfusion-related viruses, including zika virus (ZIKV) and West Nile virus (WNV).

Contact Information

Phone: +1 (212) 570-3459

Lab Personnel

  • Shibo Jiang, MD, PhD, Laboratory Co-Head
  • Wanbo Tai, PhD, Research Fellow
  • Shan Su, MD, Visiting Scientist, PhD Student
  • Yaning Gao, M.Sc., Visiting Scientist​​, PhD Student
  • Ron Rowe, BS, Lab Assistant

Funding Support

  • 1R01AI139092 Du (PI)  05/2018 – 04/2023 “Structure of best-design of coronovirus subunit vaccine”
  • NIH R01AI137472   Du (PI)  02/2018 – 01/2023 “Rational design and evaluation of novel mRNA vaccines against MERS-CoV”
  • NIH R21 AI128311  Du (PI) 12/2016– 11/2018 “A novel nanobody with good druggability to prevent and treat MERS-CoV infection”

Education and Training

Doctoral Training
PhD, University of Hong Kong
Postdoctoral Training
Lindsley F. Kimball Research Institute, New York Blood Center​